»ó´Ü¿©¹é
±â»ç (Àüü 1,380°Ç)
[Conference Report] ÇÇ¿À±Û¸®Å¸Á¸, SGLT-2iÀÇ ÀÌ»óÀûÀÎ ÆÄÆ®³Ê Á¤¿¬ÁÖ ±âÀÚ 2024-04-26 15:13
[Conference Report] ASCVD¡¤´ç´¢º´¡¤CKD µ¿¹Ý ÀÌ»óÁöÁúÇ÷Áõ ȯÀÚÀÇ ¸ÂÃãÄ¡·á Àü·«Àº? ÀÌ»óµ· ±âÀÚ 2024-04-24 09:50
[Conference Report] "°­·ÂÇÑ LDL-C °­ÇÏÈ¿°ú¿Í Æø³ÐÀº ½ÉÇ÷°ü ÇýÅÃ
Ç÷´ç ¾ÈÀü¼ºµµ °âºñÇÑ Ä¡·á¿É¼Ç"
Á¤¿¬ÁÖ ±âÀÚ 2024-04-15 10:49
[Conference Report] SGLT-2i/TZD º´¿ëÀ¸·Î Ç÷´ç¡¤Ã¼Áß¡¤Ç÷¾Ð¡¤HF¡¤CKD¡¤NAFLD °ø·« THE MOST 2024-04-11 14:05
[Interview] ¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³­µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡± ÀÌ»óµ· ±âÀÚ 2024-04-08 17:02
¶óÀÎ
[Journal Briefing] º¨ÆäµµÀÍ»ê, ½ºÅ¸Æ¾ ºÒ³»¾à¼º ȯÀÚ¿¡¼­ ½ÉÇ÷°ü ÇýÅà ½Ã»ç Á¤¿¬ÁÖ ±âÀÚ 2024-04-05 09:15
[Journal Briefing] Çѱ¹ÀÎ ´ç´¢º´-½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ Àνķü ÇÏÀ§±Ç Á¤¿¬ÁÖ ±âÀÚ 2024-04-04 09:47
[RTM] ÃÖÀûÀÇ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®¸¦ À§ÇÑ
½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾ Àü·«ÀÇ ÀÓ»óÀû ¿ªÇÒ
THE MOST 2024-03-27 17:46
[RTM] ÇÇŸ¹Ù½ºÅ¸Æ¾, ÇÇŸ¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê THE MOST 2024-03-27 16:34
[RTM] ±¹³» ¸¸¼ºÁúȯ °ü¸®Àü·«ÀÇ ÇöÀç¿Í °úÁ¦ THE MOST 2024-03-15 17:35
¶óÀÎ
[Sub Story] Àν¶¸°ºÐºñ´É¡¤Àν¶¸°ÀúÇ×¼º °³¼±±âÀüÀÌ Ã³¹æ½ÃÀå ¾çºÐ ÀÌ»óµ· ±âÀÚ 2024-03-15 17:04
[Journal Briefing] ¿¬ 2ȸ Åõ¿©, °íÇ÷¾Ð Ä¡·á Æǵµ ¹Ù²ð ¼öµµ Á¤¿¬ÁÖ ±âÀÚ 2024-03-15 16:57
[Clinical Update] NAFLD & ºñ¸¸¡¤´ç´¢º´ µ¿¹ÝÀÌȯ °¡´É¼º Çö½Ç·Î ÀÌ»óµ· ±âÀÚ 2024-03-13 15:20
[Drug Review] ÄÉ·»µð¾ÆÁ¤ Çã°¡¡¤±Þ¿©·Î
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴 Ä¡·á ¿ÏÀüü °¡µ¿
ÀÌ»óµ· ±âÀÚ 2024-03-13 14:56
[Sub Story] Ç×°íÇ÷¾ÐÁ¦+½ºÅ¸Æ¾ º´¿ëÄ¡·á´Â ±Ù°ÅÁß½ÉÀÇÇÐ ´ëÇ¥»ç·Ê ÀÌ»óµ· ±âÀÚ 2024-03-13 14:48
¶óÀÎ
[Late Breaking Studies] ÇÇŸ¹Ù½ºÅ¸Æ¾, Á׻󵿸ưæÈ­Áõ ÅðÇà °¡´É¼º ½Ã»ç Á¤¿¬ÁÖ ±âÀÚ 2024-03-13 14:32
[Sub Story] Çѱ¹ÀÎ ´ç´¢º´ º´Å»ý¸®´Â ºñºö¹äÇü ÀÌ»óµ· ±âÀÚ 2024-03-12 15:41
[Sub Story] ½ºÅ¸Æ¾, ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ±â¿© ÀÌ»óµ· ±âÀÚ 2024-03-12 14:52
[Cover Story] Çѱ¹ÀÎ ¸¸¼ºÁúȯÀº ¿ë±¤·Î¡¤ºñºö¹äÀÌÀÚ º¹ÇÕÇü ÀÌ»óµ· ±âÀÚ 2024-03-12 09:08
[Journal Briefing] 3Á¦º¹ÇÕÁ¦, Ç÷¾Ð¡¤ÁöÁú °³¼±È¿°ú ´Üµ¶º¸´Ù ¿ì¼ö Á¤¿¬ÁÖ ±âÀÚ 2024-02-20 11:01
Back to Top